These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 9973448

  • 21. A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening.
    Saulquin X, Ibisch C, Peyrat MA, Scotet E, Hourmant M, Vie H, Bonneville M, Houssaint E.
    Eur J Immunol; 2000 Sep; 30(9):2531-9. PubMed ID: 11009086
    [Abstract] [Full Text] [Related]

  • 22. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

  • 23. Epstein-Barr virus-specific cytotoxic T lymphocyte responses in the blood and tumor site of Hodgkin's disease patients: implications for a T-cell-based therapy.
    Chapman AL, Rickinson AB, Thomas WA, Jarrett RF, Crocker J, Lee SP.
    Cancer Res; 2001 Aug 15; 61(16):6219-26. PubMed ID: 11507075
    [Abstract] [Full Text] [Related]

  • 24. Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.
    Catalina MD, Sullivan JL, Bak KR, Luzuriaga K.
    J Immunol; 2001 Oct 15; 167(8):4450-7. PubMed ID: 11591771
    [Abstract] [Full Text] [Related]

  • 25. Clonotype selection and composition of human CD8 T cells specific for persistent herpes viruses varies with differentiation but is stable over time.
    Iancu EM, Corthesy P, Baumgaertner P, Devevre E, Voelter V, Romero P, Speiser DE, Rufer N.
    J Immunol; 2009 Jul 01; 183(1):319-31. PubMed ID: 19542443
    [Abstract] [Full Text] [Related]

  • 26. A functional link for major TCR expansions in healthy adults caused by persistent Epstein-Barr virus infection.
    Silins SL, Cross SM, Krauer KG, Moss DJ, Schmidt CW, Misko IS.
    J Clin Invest; 1998 Oct 15; 102(8):1551-8. PubMed ID: 9788968
    [Abstract] [Full Text] [Related]

  • 27. Search for correlation of CD8 T cell response to Epstein-Barr virus with clinical status in rheumatoid arthritis: a 15 month followup pilot study.
    Berthelot JM, Saulquin X, Coste-Burel M, Peyrat MA, Echasserieau K, Bonneville M, Houssaint E.
    J Rheumatol; 2003 Aug 15; 30(8):1673-9. PubMed ID: 12913921
    [Abstract] [Full Text] [Related]

  • 28. A method to increase tetramer staining efficiency of CD8+ T cells with MHC-peptide complexes: therapeutic applications in monitoring cytotoxic T lymphocyte activity during hepatitis B and C treatment.
    Tsai SL, Lee TH, Chien RN, Liao SK, Lin CL, Kuo GC, Liaw YF.
    J Immunol Methods; 2004 Feb 01; 285(1):71-87. PubMed ID: 14871536
    [Abstract] [Full Text] [Related]

  • 29. Aberrant Epstein-Barr virus persistence in HIV carriers is characterized by anti-Epstein-Barr virus IgA and high cellular viral loads with restricted transcription.
    Stevens SJ, Smits PH, Verkuijlen SA, Rockx DA, van Gorp EC, Mulder JW, Middeldorp JM.
    AIDS; 2007 Oct 18; 21(16):2141-9. PubMed ID: 18090040
    [Abstract] [Full Text] [Related]

  • 30. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
    Niller HH, Wolf H, Minarovits J.
    Autoimmunity; 2008 May 18; 41(4):298-328. PubMed ID: 18432410
    [Abstract] [Full Text] [Related]

  • 31. Human peripheral blood and bone marrow Epstein-Barr virus-specific T-cell repertoire in latent infection reveals distinct memory T-cell subsets.
    Guerreiro M, Na IK, Letsch A, Haase D, Bauer S, Meisel C, Roemhild A, Reinke P, Volk HD, Scheibenbogen C.
    Eur J Immunol; 2010 Jun 18; 40(6):1566-76. PubMed ID: 20232341
    [Abstract] [Full Text] [Related]

  • 32. HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.
    Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA.
    J Immunol; 2012 May 01; 188(9):4671-80. PubMed ID: 22461701
    [Abstract] [Full Text] [Related]

  • 33. Immune surveillance against Epstein-Barr virus.
    Moss DJ, Burrows SR, Khanna R, Misko IS, Sculley TB.
    Semin Immunol; 1992 Apr 01; 4(2):97-104. PubMed ID: 1377517
    [Abstract] [Full Text] [Related]

  • 34. Epstein-Barr virus evasion of CD8(+) and CD4(+) T cell immunity via concerted actions of multiple gene products.
    Ressing ME, Horst D, Griffin BD, Tellam J, Zuo J, Khanna R, Rowe M, Wiertz EJ.
    Semin Cancer Biol; 2008 Dec 01; 18(6):397-408. PubMed ID: 18977445
    [Abstract] [Full Text] [Related]

  • 35. Long-term carriers generate Epstein-Barr virus (EBV)-specific CD4(+) and CD8(+) polyfunctional T-cell responses which show immunodominance hierarchies of EBV proteins.
    Ning RJ, Xu XQ, Chan KH, Chiang AK.
    Immunology; 2011 Oct 01; 134(2):161-71. PubMed ID: 21896011
    [Abstract] [Full Text] [Related]

  • 36. An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness.
    Ouyang Q, Wagner WM, Walter S, Müller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G.
    Mech Ageing Dev; 2003 Apr 01; 124(4):477-85. PubMed ID: 12714256
    [Abstract] [Full Text] [Related]

  • 37. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 38. Ex vivo profiling of CD8+-T-cell responses to human cytomegalovirus reveals broad and multispecific reactivities in healthy virus carriers.
    Elkington R, Walker S, Crough T, Menzies M, Tellam J, Bharadwaj M, Khanna R.
    J Virol; 2003 May 15; 77(9):5226-40. PubMed ID: 12692225
    [Abstract] [Full Text] [Related]

  • 39. Intrathecal CD8 T-cells of multiple sclerosis patients recognize lytic Epstein-Barr virus proteins.
    van Nierop GP, Mautner J, Mitterreiter JG, Hintzen RQ, Verjans GM.
    Mult Scler; 2016 Mar 15; 22(3):279-91. PubMed ID: 26041797
    [Abstract] [Full Text] [Related]

  • 40. Selection of a diverse TCR repertoire in response to an Epstein-Barr virus-encoded transactivator protein BZLF1 by CD8+ cytotoxic T lymphocytes during primary and persistent infection.
    Silins SL, Cross SM, Elliott SL, Pye SJ, Burrows JM, Moss DJ, Misko IS.
    Int Immunol; 1997 Nov 15; 9(11):1745-55. PubMed ID: 9418135
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.